These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9689899)

  • 1. Synthesis and in vitro microsomal metabolism of 4-ethyl-5-(4-fluorophenyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione and its potential metabolites.
    Gülerman N; Rollas S; Ulgen M
    Boll Chim Farm; 1998 May; 137(5):140-3. PubMed ID: 9689899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-pressure liquid chromatographic analysis for identification of in vitro and in vivo metabolites of 4-phenethyl-5-[4-(1-(2-hydroxyethyl)-3,5-dimethyl-4-pyrazolylazo)phenyl]-2,4-dihydro-3H-1,2,4-triazole-3-thione in rats.
    Kaymakçioğlu BK; Oruç EE; Unsalan S; Kabasakal L; Rollas S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Feb; 831(1-2):184-9. PubMed ID: 16378765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in vivo metabolism of 5-(4-nitrophenyl)-4-phenyl-2,4-dihydro-3H-1,2,4-triazole-3-thione in rats.
    Oruç EE; Rollas S; Kabasakal L; Uysal MK
    Drug Metabol Drug Interact; 1999; 15(2-3):127-40. PubMed ID: 10707119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human liver microsomal reduction of pyrrolizidine alkaloid N-oxides to form the corresponding carcinogenic parent alkaloid.
    Wang YP; Yan J; Fu PP; Chou MW
    Toxicol Lett; 2005 Mar; 155(3):411-20. PubMed ID: 15649625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro biotransformation of 3,4-dihydro-6-hydroxy-2,2-dimethyl-7-methoxy-1(2H)-benzopyran (CR-6), a potent lipid peroxidation inhibitor and nitric oxide scavenger, in rat liver microsomes.
    Yenes S; Commandeur JN; Vermeulen NP; Messeguer A
    Chem Res Toxicol; 2004 Jul; 17(7):904-13. PubMed ID: 15257615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of two phase I metabolites of bendamustine in human liver microsomes and in cancer patients treated with bendamustine hydrochloride.
    Teichert J; Baumann F; Chao Q; Franklin C; Bailey B; Hennig L; Caca K; Schoppmeyer K; Patzak U; Preiss R
    Cancer Chemother Pharmacol; 2007 May; 59(6):759-70. PubMed ID: 16957931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in vitro hepatic metabolism of 1-phenyl-2-(2-benzothiazolinone-3-yl)ethanone and their reduced derivatives.
    Yilmaz F; Ulgen M; Doğruer DS; Cakir B; Sahin MF
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):442-5. PubMed ID: 10445413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro microsomal metabolic studies on secondary aromatic amides.
    Ulgen M; Ercak K; Kucukguzel I; Gorrod JW
    Boll Chim Farm; 1997 Oct; 136(9):600-4. PubMed ID: 9440353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective metabolism of E-3,4-bis(4-ethylphenyl)hex-3-ene in rat liver microsomes.
    Fabian EJ; Metzler M
    Arch Toxicol; 2006 Jan; 80(1):17-26. PubMed ID: 16187102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro identification of metabolites of verapamil in rat liver microsomes.
    Sun L; Zhang SQ; Zhong DF
    Acta Pharmacol Sin; 2004 Jan; 25(1):121-8. PubMed ID: 14704133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro metabolism study of combretastatin A-4 in rat and human liver microsomes.
    Aprile S; Del Grosso E; Tron GC; Grosa G
    Drug Metab Dispos; 2007 Dec; 35(12):2252-61. PubMed ID: 17890446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, cytotoxicity and effects of some 1,2,4-triazole and 1,3,4-thiadiazole derivatives on immunocompetent cells.
    Mavrova ATs; Wesselinova D; Tsenov YA; Denkova P
    Eur J Med Chem; 2009 Jan; 44(1):63-9. PubMed ID: 18439727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in vitro hepatic microsomal metabolism of methyl 2-(2(3H)-benzoxazolone-3-yl)acetate in rats.
    Ulgen M; Yilmaz F; Doğruer DS; Sahin MF
    Drug Metabol Drug Interact; 1999; 15(2-3):173-9. PubMed ID: 10707122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro hepatic microsomal metabolism of N-benzyl-N-methylaniline.
    Küçükgüzel I; Ulgen M; Gorrod JW
    Farmaco; 1999 May; 54(5):331-7. PubMed ID: 10418125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of the dipeptidyl peptidase 4 inhibitor sitagliptin in rats and dogs.
    Beconi MG; Reed JR; Teffera Y; Xia YQ; Kochansky CJ; Liu DQ; Xu S; Elmore CS; Ciccotto S; Hora DF; Stearns RA; Vincent SH
    Drug Metab Dispos; 2007 Apr; 35(4):525-32. PubMed ID: 17220241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in vitro hepatic microsomal metabolism of 3,5-dimethyl-4-(phenylazo)-(1H)-pyrazole in rats.
    Kaymakçioğlu B; Oruç E; Ulgen M; Rollas S
    Drug Metabol Drug Interact; 1999; 15(2-3):107-14. PubMed ID: 10707117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of roxithromycin in phenobarbital-treated rat liver microsomes.
    Zhong DF; Zhang SQ; Sun L; Zhao XY
    Acta Pharmacol Sin; 2002 May; 23(5):455-60. PubMed ID: 11978197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of the A(1)1 adenosine receptor positron emission tomography ligand [18F]8-cyclopentyl-3-(3-fluoropropyl)-1-propylxanthine ([18F]CPFPX) in rodents and humans.
    Bier D; Holschbach MH; Wutz W; Olsson RA; Coenen HH
    Drug Metab Dispos; 2006 Apr; 34(4):570-6. PubMed ID: 16415116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic transformations of antitumor imidazoacridinone, C-1311, with microsomal fractions of rat and human liver.
    Wiśniewska A; Chrapkowska A; Kot-Wasik A; Konopa J; Mazerska Z
    Acta Biochim Pol; 2007; 54(4):831-8. PubMed ID: 18084652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.